Skip to Content

Join the 'Nivolumab' group to help and get support from people like you.

Nivolumab Support Group

Latest News

FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) Combination as First-Line Treatment for Patients with Intermediate- and Poor-Risk Advanced Renal Cell Carcinoma

PRINCETON, N.J.--(BUSINESS WIRE) April 16, 2018 --Bristol-Myers Squibb Company (NYSE: BMY) today announced that Opdivo (nivolumab) 3 mg/kg plus Yervoy (ipilimumab) 1 mg/kg (injections for intravenous ...

Read more news...

Latest Questions

View more questions...

Top Group Members

Babyg2016
2 total answers
Marvell
14,356 answers
robo
3,801 answers
paulyboy
92 answers
JCSCobb
1 answer
Traceydoll
0 answers

View all 11 members...

Ask a Question